All Stories

  1. Insight into Discovery of Next Generation Reversible TMLR Inhibitors Targeting EGFR Activating and Drug Resistant T790M Mutants

    Article • Current Cancer Drug Targets, August 2017, Bentham Science Publishers

    Dr Subhash Mohan Agarwal, Miss DIVYANI Pal